ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
2,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8,2,Prostatitis,Prostate and seminal vesicles infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
9,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
12,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
13,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
14,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
14,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
14,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
15,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
15,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,3,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
16,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
17,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
20,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
22,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
23,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
24,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
25,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
26,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
27,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
28,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
29,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
30,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
31,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
32,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
32,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
33,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
33,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
34,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
35,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
35,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
37,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
39,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
39,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
39,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
40,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
41,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
41,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
41,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
42,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
43,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
43,2,Headache,Headaches NEC,Headaches,Nerv,N
43,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
44,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
44,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
45,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
45,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
46,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
46,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
46,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
47,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
47,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
48,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
49,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
50,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
51,2,Measles,Rubeola viral infections,Viral infectious disorders,Infec,N
51,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
52,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
52,2,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
52,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
52,4,Measles,Rubeola viral infections,Viral infectious disorders,Infec,N
52,5,Measles,Rubeola viral infections,Viral infectious disorders,Infec,N
53,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
53,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
53,3,Fat embolism,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
53,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
53,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
53,6,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
53,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
54,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
56,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
56,2,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
57,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
59,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
59,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
60,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
61,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
62,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
63,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
63,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
63,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
64,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
65,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
65,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
68,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
68,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
68,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
68,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
69,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
70,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
71,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
71,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
72,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
72,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
73,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
73,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
73,3,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
74,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
75,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
75,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
75,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
75,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
75,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
76,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
76,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
76,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
77,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
77,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
78,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
79,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
79,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
80,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
80,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
81,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
81,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
81,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
82,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
82,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
82,6,Headache,Headaches NEC,Headaches,Nerv,N
82,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
82,8,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
82,10,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
82,11,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
82,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,13,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
82,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
83,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
83,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
84,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
84,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
84,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
85,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
85,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
85,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
86,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
87,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
88,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
88,2,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
89,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
90,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
92,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
92,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
93,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
94,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
94,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
94,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,4,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
94,5,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
95,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
96,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
97,1,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
97,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
97,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
98,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
101,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
102,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
103,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
103,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
103,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
103,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
103,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
104,1,Anotia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
104,2,External ear disorder,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
105,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,1,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
111,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
113,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
113,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
113,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
113,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
114,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
115,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
116,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
117,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
118,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
119,1,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
120,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
121,1,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
122,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
122,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
122,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
122,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
122,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
124,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
125,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
126,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
127,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
127,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
129,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
130,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
130,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
130,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
131,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
132,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
133,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
133,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
134,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
134,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
134,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
134,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
134,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,1,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
135,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
136,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
136,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
136,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
136,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
136,5,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
136,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
137,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
137,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
137,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
138,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
138,2,Headache,Headaches NEC,Headaches,Nerv,N
139,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
140,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
141,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
141,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,3,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
142,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
143,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
144,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
145,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
146,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
146,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
147,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
148,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
149,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
149,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
149,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
149,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
150,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
151,1,Pelvi-ureteric obstruction,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
151,2,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
152,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
153,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
155,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
155,2,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
156,1,Large intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
156,2,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
157,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
157,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
157,3,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
157,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
158,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
158,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
158,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
158,4,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
158,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
158,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
158,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
160,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
162,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
163,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
163,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
164,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
165,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
165,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
167,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
168,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
168,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
168,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
168,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
168,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
169,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
170,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
171,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
172,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
172,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,1,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
173,2,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
174,1,Radioisotope scan abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
175,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
175,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
175,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
176,1,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
176,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
177,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
177,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
177,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
177,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
177,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
178,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
179,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
179,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
180,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
181,1,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
182,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
182,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
182,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
183,1,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
183,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
183,3,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
184,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
184,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
184,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
184,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
185,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
185,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
186,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
186,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
186,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
187,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
187,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
187,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
188,1,Oculoauriculovertebral dysplasia,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
189,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
189,2,Ligament disorder,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
189,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
189,4,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
189,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
189,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
189,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,9,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
190,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
191,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
192,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
193,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
193,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
193,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
193,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
194,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
195,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
196,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
197,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
197,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
197,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
198,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
199,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
200,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
200,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
200,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
201,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
202,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
203,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
203,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
203,3,Postoperative ileus,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
203,4,Vesicoureteral reflux surgery,Ureteric therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
204,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
206,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
206,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
206,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
206,4,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
206,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
206,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
206,7,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
206,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
206,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
206,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
206,11,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
206,12,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
207,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
207,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
207,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
208,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
209,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
209,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
210,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
211,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
212,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
212,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
212,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,4,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
213,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
214,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
214,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
215,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
216,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
216,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
216,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
216,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
217,1,Spermatozoa progressive motility decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
218,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
218,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
219,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
220,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
221,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
222,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
223,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
223,2,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
224,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
224,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
224,3,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
225,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
225,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
225,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
225,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
225,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
225,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
226,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
227,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
228,1,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
229,1,Lipids abnormal,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
230,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
231,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
233,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
234,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
234,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
236,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
236,3,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
236,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
236,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
236,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
236,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
237,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
237,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
238,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
238,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
238,3,Headache,Headaches NEC,Headaches,Nerv,N
238,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
240,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
241,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
242,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
242,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
242,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
242,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
242,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
243,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
243,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
244,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
245,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
245,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
245,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
245,4,Acid fast bacilli infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
245,5,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
245,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
245,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
245,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
245,9,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
245,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,11,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
245,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
245,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
245,14,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
245,15,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
245,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
245,17,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
245,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,19,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
245,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
245,21,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
245,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
246,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
246,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
247,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
247,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
247,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
248,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,2,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
249,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
249,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
250,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
250,2,Headache,Headaches NEC,Headaches,Nerv,N
250,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
250,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
251,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
252,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
252,3,Migraine,Migraine headaches,Headaches,Nerv,N
253,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
254,1,Gastroenteritis eosinophilic,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
255,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
256,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
256,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
257,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
257,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
258,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
258,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
258,3,Kidney enlargement,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
258,4,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,5,Ureteric stenosis,Ureteric disorders NEC,Ureteric disorders,Renal,N
259,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
259,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
260,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
261,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
261,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
261,3,Dilatation ventricular,Myocardial disorders NEC,Myocardial disorders,Card,N
261,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
261,5,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
261,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
261,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
261,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
261,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
262,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
262,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
262,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
262,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
263,2,Oxalosis,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
264,1,Coloboma,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
264,2,External auditory canal atresia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
264,3,Iris coloboma,Iris and choroid disorders congenital,Eye disorders congenital,Cong,N
264,4,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
265,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
266,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
267,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
267,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
268,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
268,3,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
268,4,Corneal transplant,Corneal and scleral therapeutic procedures,Eye therapeutic procedures,Surg,N
268,5,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
268,6,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
268,7,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
268,8,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
269,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
269,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
269,4,Moraxella infection,Moraxella infections,Bacterial infectious disorders,Infec,N
269,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
269,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
269,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
271,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
271,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
271,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
272,1,Headache,Headaches NEC,Headaches,Nerv,N
273,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
273,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
273,3,Non-cardiogenic pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
274,1,Dissociative disorder,Dissociative states,Dissociative disorders,Psych,N
274,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
274,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
275,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
275,2,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
275,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
276,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
276,2,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
276,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
277,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
277,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
278,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
278,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
278,3,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
278,4,Complications of transplant surgery,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
278,5,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
278,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
278,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
278,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
278,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
278,11,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
278,12,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
278,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
278,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
279,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
279,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
279,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
279,4,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
279,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
279,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
279,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
279,8,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
279,10,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
279,11,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
280,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
281,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
282,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
282,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
282,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
282,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
283,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
284,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
284,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
284,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
284,4,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
284,5,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
284,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
284,7,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
285,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
285,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
285,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,4,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
286,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
286,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
286,3,Aspiration bone marrow abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
286,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
286,5,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
286,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
286,7,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
286,8,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
286,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
286,10,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
286,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
286,12,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
286,13,Rheumatoid factor positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
286,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
287,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
288,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
289,1,Selective IgA immunodeficiency,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
290,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
290,2,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
290,3,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
290,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
291,1,Selective IgA immunodeficiency,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
292,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,1,Selective IgA immunodeficiency,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
295,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
296,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
297,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
297,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
297,4,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
297,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
297,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
298,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
298,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
298,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
299,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
300,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
300,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
300,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
301,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
302,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
303,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
303,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
304,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
304,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
304,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
305,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
305,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
306,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
306,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
306,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
307,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
308,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
308,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
309,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
310,1,Burkholderia cepacia complex infection,Burkholderia infections,Bacterial infectious disorders,Infec,N
311,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
311,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
311,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
311,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
311,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
311,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
311,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
311,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
311,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
311,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
311,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
311,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
311,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
311,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
311,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
311,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
311,18,Myopathy,Myopathies,Muscle disorders,Musc,N
311,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
311,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
311,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
311,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
311,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
311,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
311,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
311,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
311,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
312,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
313,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
313,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
314,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
314,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
314,3,Hyperoxaluria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
314,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
315,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
316,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
316,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
317,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
317,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
317,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
317,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
317,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
317,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
317,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
317,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
317,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
317,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
318,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
318,2,Rectal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
319,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,2,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
319,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
319,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
320,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
320,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
321,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
321,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
321,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
322,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
322,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
322,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
323,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
324,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
325,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
325,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
325,3,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
325,4,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
326,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
327,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
328,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
329,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
330,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
330,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
331,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
331,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
331,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
331,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
332,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
332,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
333,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
333,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
333,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
333,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
335,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
335,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
336,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
336,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
336,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
337,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
338,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
338,2,Spinal cord abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
338,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
339,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
339,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
339,3,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
339,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
339,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
339,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
340,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
341,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
341,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
342,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
342,2,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
342,3,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
342,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
343,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
343,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
343,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
343,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
343,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
344,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
344,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
344,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
345,2,Aneurysm ruptured,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
345,3,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
345,4,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
345,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
345,6,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
345,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
345,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,9,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
345,10,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
345,11,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
345,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
345,13,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
345,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,15,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
345,16,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
345,17,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
345,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
345,19,Splenic artery aneurysm,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
346,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
346,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
347,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
347,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
347,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
347,4,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
348,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
348,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
349,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
349,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
349,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
349,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
351,1,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
352,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
352,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
352,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
353,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
353,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
353,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
353,4,Spinal cord abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
353,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
354,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
354,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
355,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
355,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
355,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
356,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
356,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
356,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
356,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
357,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
357,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
358,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
358,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
359,1,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
360,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
360,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
361,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
362,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
362,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
362,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
362,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
362,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
362,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
362,7,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
362,8,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
362,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
362,10,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
362,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
362,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
363,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
363,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
363,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
364,2,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
364,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
365,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
366,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
366,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
366,3,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
367,1,Deafness,Hearing losses,Hearing disorders,Ear,N
368,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
368,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
369,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
370,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
370,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
370,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
370,4,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
370,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
371,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
372,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
373,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
373,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
373,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
374,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
375,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
376,1,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
377,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
378,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
379,1,Deafness,Hearing losses,Hearing disorders,Ear,N
379,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
381,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
381,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
381,4,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
381,5,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
381,6,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
381,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
381,8,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
382,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
383,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
383,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
383,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
384,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
384,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
384,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
385,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
386,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
386,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
386,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
386,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
386,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
386,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
386,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
387,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
387,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
387,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
388,1,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
389,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
389,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
389,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
389,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
390,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
390,2,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
390,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
391,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
391,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
391,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
392,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
393,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
393,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
393,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
394,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
394,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
395,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
395,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
396,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
396,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
397,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
397,2,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
397,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
397,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
397,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
397,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
398,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
398,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
399,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
400,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
401,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
401,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
402,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
402,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
402,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
402,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
403,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
403,2,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
403,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
404,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
404,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
405,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
405,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
406,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
406,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
407,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
407,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
408,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
408,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
408,3,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
409,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
409,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
409,4,Tubulointerstitial nephritis and uveitis syndrome,Nephritis NEC,Nephropathies,Renal,N
410,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
410,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
410,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
410,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
410,5,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
410,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
410,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
410,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
410,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
410,10,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
410,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
410,12,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
410,13,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
410,14,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
410,15,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
410,16,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
410,17,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
410,18,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
411,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
411,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
411,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
411,4,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
411,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
412,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
412,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
413,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
413,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
414,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
414,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
415,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
415,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
416,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
416,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
417,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
417,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
417,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
418,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
418,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
418,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
418,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
418,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
418,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
418,7,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
418,8,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
418,9,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
418,10,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
418,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
418,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
419,1,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
420,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
420,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
420,3,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
420,4,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
421,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
421,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
422,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
422,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
423,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
424,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
425,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
425,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
426,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
426,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
426,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
427,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
427,2,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
428,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
428,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
429,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
429,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
429,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
429,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
429,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
429,6,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
429,7,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
430,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
430,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
430,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
430,4,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
430,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
430,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
430,7,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
430,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,9,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
431,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
431,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
431,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
432,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
432,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
433,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
433,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
433,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
433,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
433,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
434,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
434,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
435,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
436,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
436,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
436,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
437,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
437,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
438,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
439,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
440,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
440,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
440,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
440,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
440,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
441,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
441,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
441,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
441,4,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
441,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
441,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
441,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
441,8,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
441,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
441,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
441,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
442,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
442,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
442,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
442,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
442,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
442,6,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
443,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
443,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
443,3,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
444,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
444,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
444,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
444,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
444,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
444,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
445,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
446,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
446,2,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
447,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
448,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
448,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
449,1,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
450,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
450,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
450,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,4,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
450,5,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
450,6,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
450,7,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
450,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
451,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
451,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
451,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
452,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
453,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
453,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
454,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
454,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
455,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
456,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
456,2,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
456,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
456,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
456,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
456,6,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
456,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
456,9,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
457,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
457,2,Headache,Headaches NEC,Headaches,Nerv,N
457,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
457,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
457,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
458,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
458,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
459,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
459,2,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
459,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
459,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
460,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
461,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
461,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
461,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
461,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
462,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
462,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
462,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
463,1,Migraine,Migraine headaches,Headaches,Nerv,N
464,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
464,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
464,3,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
465,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
465,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
465,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
465,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
466,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
466,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
466,3,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
466,4,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
466,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
467,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
467,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,Y
467,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
467,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
469,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
469,2,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
469,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
469,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
470,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
471,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
472,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
472,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
472,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
472,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
473,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
473,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
473,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
473,4,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
473,5,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
473,6,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
473,7,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
473,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
473,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
473,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
473,11,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
473,12,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
473,13,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
473,14,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
473,15,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
473,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
473,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
473,18,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
473,19,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
473,20,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
473,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
474,1,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
475,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
475,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
476,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
476,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
476,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
477,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
477,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
477,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
477,4,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
477,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
477,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
477,7,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
477,8,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,9,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
477,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
478,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
478,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
479,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
479,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
480,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
480,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
481,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
482,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
483,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
484,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
485,1,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
485,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
485,3,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
486,1,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
486,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
487,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
487,2,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
487,3,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
487,4,Gastrointestinal mucosal disorder,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
488,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
488,2,Gastrointestinal mucosal disorder,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
489,1,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
490,1,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
491,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
491,2,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
491,3,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
492,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
492,2,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
492,3,Viral vasculitis,Viral infections NEC,Viral infectious disorders,Infec,N
493,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
493,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
493,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
493,4,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
494,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
494,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
494,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
494,4,Right ventricular systolic pressure increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
495,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
495,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
495,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,6,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
496,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
496,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
496,3,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
496,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
498,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
498,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
499,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
500,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
501,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
502,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
503,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
504,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
504,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
504,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
504,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
504,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
504,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
504,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
504,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
504,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
504,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
505,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
506,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
507,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
508,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
508,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
508,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
508,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,6,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
508,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
508,8,SLE arthritis,Arthropathies NEC,Joint disorders,Musc,N
509,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
510,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
510,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
511,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
511,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
512,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
513,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
514,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
515,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
516,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
517,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
518,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
519,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
520,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
521,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
522,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
523,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
524,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
525,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
525,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
526,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
526,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
527,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
527,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
527,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
527,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
527,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
527,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
528,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
529,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
530,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
531,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
531,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
531,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
531,4,Gastrointestinal hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
531,5,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
531,6,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
531,7,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
531,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
532,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
532,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
532,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
532,5,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
533,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
533,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
533,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
533,4,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
533,5,Gastrointestinal hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
533,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
533,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
533,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
534,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
534,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
534,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
535,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
536,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
537,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
537,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
538,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
538,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
538,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
538,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
539,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
539,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
540,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
540,2,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
540,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
541,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
541,2,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
542,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
542,2,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
542,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
542,4,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
543,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
543,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
543,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
543,4,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
543,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
544,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
544,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
544,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
544,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
545,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
545,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
545,3,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
545,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
545,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
546,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
546,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
546,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
546,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
547,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
547,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
547,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
547,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
547,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
547,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
548,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
548,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
548,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
549,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
550,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
550,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
550,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
550,4,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
550,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
550,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
550,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
550,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
550,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
550,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
550,11,Protein-losing gastroenteropathy,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
551,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
551,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
551,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
552,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
553,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
553,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
553,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
553,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
553,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
553,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
553,7,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
553,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
553,9,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
553,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
553,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
553,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
553,13,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
553,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
554,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
554,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
554,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
554,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
555,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
556,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
557,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
558,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
559,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
559,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
560,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
560,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
561,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
562,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
562,2,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
562,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
562,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
563,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
563,2,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
563,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
564,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
564,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
564,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
565,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
565,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
565,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
566,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
566,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
567,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
567,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
568,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
568,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
568,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
569,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
569,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
571,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
571,2,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
571,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
571,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
571,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
571,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
571,7,Norovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
571,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
571,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
571,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
571,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
571,12,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
571,13,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
572,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
572,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
572,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
572,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
572,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
572,6,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
572,7,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
573,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
573,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
574,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
574,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
574,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
575,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
575,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
575,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
576,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
576,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
576,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
576,4,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
576,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
576,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
577,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
577,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
578,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
578,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
578,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
578,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
578,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
579,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
580,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
581,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
581,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
581,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
581,4,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
581,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
582,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
583,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
583,2,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
583,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
584,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
584,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
584,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
584,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
584,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
585,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
585,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
585,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
585,4,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
585,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
585,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
585,7,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
585,8,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
586,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
586,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
587,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
587,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
588,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
588,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
589,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
589,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
590,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
590,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
592,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
593,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
594,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
594,2,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
594,3,Restrictive pulmonary disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
594,4,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
595,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
596,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
596,2,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
597,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
597,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
598,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
598,2,Tuberculosis liver,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
599,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
599,2,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
599,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
599,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
599,5,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,Y
599,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
599,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
600,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
601,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
601,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
601,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
601,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
602,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
602,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
602,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
603,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
604,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
604,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
604,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
604,4,Red cell fragmentation syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
604,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
604,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
604,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
605,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
606,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
606,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
606,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
607,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
608,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
608,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
608,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
609,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
609,2,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
609,3,Infective aortitis,Vascular infections,Infections - pathogen unspecified,Infec,N
609,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
609,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
609,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
609,7,Salmonella bacteraemia,Salmonella infections,Bacterial infectious disorders,Infec,N
610,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
611,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
611,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
611,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
611,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
612,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
612,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
613,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
614,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
615,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
616,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
616,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
617,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
617,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
617,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
618,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
619,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
619,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
619,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
619,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
620,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
621,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
622,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
623,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
624,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
625,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
625,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
625,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
626,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
626,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
626,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
626,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
626,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
626,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
626,8,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
626,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
626,10,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
627,1,Benign ovarian tumour,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
628,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
628,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
628,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
628,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
629,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
630,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
630,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,1,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
631,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
631,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
632,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
633,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
633,2,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
634,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
635,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
635,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
636,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
637,1,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
637,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
637,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
638,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
639,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
640,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
640,2,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
641,1,Fungating wound,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
641,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
641,3,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
642,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
643,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
644,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
645,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
645,2,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
645,3,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
645,4,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
645,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
645,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
645,9,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,10,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
645,11,Tonsillar ulcer,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
646,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
647,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
648,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
648,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
648,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
648,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
648,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
648,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
649,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
650,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
651,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
652,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
653,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
653,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
653,3,Femoral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
653,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,5,Peripheral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
653,6,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
653,7,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
653,8,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
653,9,Vascular stent thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
654,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
654,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
655,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
655,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
655,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
656,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
657,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
658,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
659,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
659,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
660,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
661,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
662,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
663,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
663,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
663,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
663,4,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
663,5,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
663,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
663,7,Migraine,Migraine headaches,Headaches,Nerv,N
663,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
663,9,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
663,10,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
664,1,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
664,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
664,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
664,4,Poikilocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
664,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
664,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
665,1,Phantom limb syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
666,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
666,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
667,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
667,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
668,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
668,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
668,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
669,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
669,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
669,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
670,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
670,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
671,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
671,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
672,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
673,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
673,2,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
674,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
675,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
676,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
677,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
678,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
679,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
679,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
679,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
679,4,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
679,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
679,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
679,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
679,8,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
679,9,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
679,10,Sapovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
680,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
681,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
681,2,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
681,3,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
681,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
681,6,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
682,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
683,1,Colitis erosive,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
683,2,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
683,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
684,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
684,2,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
684,3,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
684,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
684,5,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
685,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
685,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
685,3,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
686,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
686,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
686,3,Intestinal villi atrophy,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
687,1,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
687,2,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
687,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
687,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
688,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
688,3,Cytomegalovirus gastrointestinal infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
689,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
689,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
689,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
690,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
690,2,Enterocolitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
690,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
690,4,Viral vasculitis,Viral infections NEC,Viral infectious disorders,Infec,N
691,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
691,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
691,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
692,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
692,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
692,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
692,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
693,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
693,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
694,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
694,2,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
695,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
695,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
695,3,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
696,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
696,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
697,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
698,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
699,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
700,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
701,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
701,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
702,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
703,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
703,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
703,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
704,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
705,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
706,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
706,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
706,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
706,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
706,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
707,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
708,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
708,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
708,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
708,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
708,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
708,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
709,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
710,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
711,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
712,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
712,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
713,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
713,2,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
713,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
713,4,Haemangioma of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
713,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
713,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
713,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
713,8,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
713,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
714,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
715,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
715,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
715,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
715,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
715,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
715,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
715,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
716,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
717,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
718,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
719,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
720,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
721,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
722,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
723,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
724,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
725,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
726,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
726,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
727,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
727,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
728,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
728,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
728,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
729,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
729,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
730,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
731,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
732,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
732,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
733,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
733,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
735,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
736,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
737,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
738,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
738,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
739,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
740,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
741,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
741,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
742,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
742,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
743,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
743,2,Mediastinal abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
743,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
743,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
744,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
744,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,4,Macular scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
745,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
746,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
747,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
748,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
749,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
749,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
750,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
750,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
750,3,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
750,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
751,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
751,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
751,3,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
752,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
753,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
754,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
755,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
756,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
757,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
758,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
759,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
759,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
760,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
760,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
760,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
761,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
762,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
762,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
762,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
762,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
763,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
764,1,Viral test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
765,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
766,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
767,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
767,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
768,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
769,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
770,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
770,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
770,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
770,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
770,5,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
770,6,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
770,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
770,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
771,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
772,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
772,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
772,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
772,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
772,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
772,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,Y
772,7,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
772,8,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
772,9,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
772,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
773,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
774,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
775,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
775,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
776,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
776,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
777,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
777,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
778,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
778,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
779,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
780,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
780,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
780,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
780,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
781,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
782,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
783,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
784,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
784,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
785,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
786,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
786,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
787,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
788,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
789,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
790,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
791,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
792,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
793,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
793,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
793,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
793,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
794,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
794,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
795,1,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
796,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
796,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
797,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
797,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
798,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
798,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
798,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
798,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
798,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
799,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
799,2,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
800,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
800,2,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
801,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
802,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
802,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
802,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
802,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
803,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
804,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
805,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
806,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
807,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
807,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
807,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
807,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
808,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
809,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
810,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
810,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
811,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
813,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
814,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
815,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
816,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
817,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
817,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
818,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
819,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
820,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
821,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
822,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
826,1,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
827,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
827,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
827,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
827,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
828,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
829,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
829,2,Cutaneous T-cell lymphoma stage III,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
829,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
830,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
831,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
831,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
832,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
833,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
833,2,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
833,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
833,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
834,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
835,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
836,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
836,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
837,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
838,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
839,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
840,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
841,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
842,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
843,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
844,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
845,1,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
846,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
846,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
846,3,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
846,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
846,5,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
846,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
846,7,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
846,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
846,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
847,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
848,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
849,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
850,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
850,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
850,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
851,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
851,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
851,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
852,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
853,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
853,2,Headache,Headaches NEC,Headaches,Nerv,N
854,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
855,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
855,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
855,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
855,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
855,5,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
855,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
855,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
855,8,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
855,9,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
855,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
855,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
855,12,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
855,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
856,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
857,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
857,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
857,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
857,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
857,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
857,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
857,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
858,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
858,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
859,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
860,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
860,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
860,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,4,Illogical thinking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
860,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
860,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
860,7,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
860,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
861,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
862,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
863,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
864,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
865,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
866,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
867,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
868,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
868,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
868,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
868,4,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
868,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
868,6,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
868,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
869,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
869,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
869,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
870,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
871,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
872,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
873,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
874,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
874,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
874,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
875,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
876,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
877,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
878,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
879,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
880,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
880,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
881,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
882,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
883,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
883,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
883,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
883,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
883,5,Spindle cell sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,Y
884,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
885,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
885,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
886,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
887,1,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
887,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
887,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
888,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
889,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
889,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
889,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
889,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
889,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
890,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
891,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
892,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
893,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
894,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
895,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
895,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
896,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
897,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
897,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
897,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
897,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
897,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
897,6,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
897,7,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
897,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
897,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
897,10,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
897,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
898,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
898,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
898,3,Urethral stent insertion,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
898,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
899,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
902,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
902,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
903,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
903,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
903,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
903,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
903,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
904,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
905,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
905,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
905,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
906,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
907,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
907,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
907,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
907,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
907,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
908,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
908,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
909,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
910,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
911,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
912,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
912,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
912,3,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
912,4,Parakeratosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
913,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
913,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
913,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
913,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
913,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
914,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
915,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
915,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
915,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
915,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
915,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
915,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
916,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
916,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
916,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
916,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
917,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
918,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
919,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
920,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
920,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
920,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
921,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
922,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
923,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
923,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
923,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
923,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
924,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
925,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
926,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
926,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
926,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
927,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
928,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
929,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
930,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
930,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
931,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
932,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
933,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
934,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
935,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
936,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
936,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
937,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
937,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
937,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
937,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
937,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
938,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
938,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
939,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
939,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
939,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
939,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
939,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
940,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
941,1,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
942,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
942,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
942,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
943,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
944,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
945,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
946,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
946,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
946,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
947,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
948,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
948,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
949,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
949,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
950,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
951,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
952,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
952,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
952,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
952,4,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
952,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
952,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
952,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
953,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
954,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
955,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
955,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
956,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
956,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
957,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
958,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
959,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
959,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
960,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
960,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
961,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
962,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
963,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
964,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
964,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
965,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
965,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
966,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
967,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
968,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
968,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
969,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
969,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
970,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
970,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
971,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
972,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
973,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
974,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
975,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
975,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
976,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
976,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
977,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
978,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
979,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
980,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
980,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
981,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
982,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
983,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
984,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
984,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
986,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
987,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
988,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
989,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
989,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
989,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
989,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
989,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
989,6,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
989,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
989,8,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
989,9,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
989,10,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
989,11,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
989,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
989,13,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
989,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
989,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
989,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
989,17,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
989,18,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
990,1,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
990,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
991,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
991,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
991,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
991,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
992,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
993,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
993,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
994,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
995,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
996,1,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
997,1,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
998,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
999,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1000,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1001,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1001,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1001,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1001,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1001,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1002,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1003,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1004,1,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
1005,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1006,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1007,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1008,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1009,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1010,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1011,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1011,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1012,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1013,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1013,2,Conjunctival scar,Eye injuries NEC,Injuries NEC,Inj&P,N
1013,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1013,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1015,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1017,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1018,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1018,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1019,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1019,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1020,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1020,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1021,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1022,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
1023,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1024,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1025,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1026,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1027,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1028,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1028,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1028,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1028,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1028,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1028,6,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1028,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1029,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1030,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1031,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1032,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1033,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1034,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1034,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1035,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1036,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1037,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1037,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1038,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1038,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1039,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1039,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1040,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1041,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1042,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1043,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1043,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1044,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1045,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1046,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1047,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1048,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1048,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1049,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1050,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1051,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1052,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1053,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1053,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1054,1,Transient acantholytic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1055,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1055,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1056,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1057,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1058,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1059,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1059,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1060,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1060,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1060,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1061,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1062,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
1063,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1064,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1065,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1066,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1067,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1068,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1069,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1070,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1070,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1071,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1072,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1073,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1074,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1075,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1076,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1077,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1078,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1079,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1080,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1081,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1082,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1082,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1082,3,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1082,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1084,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1085,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
1086,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1087,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1087,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1088,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1089,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1090,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1091,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1091,2,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
1091,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1091,4,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1091,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1092,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1092,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1092,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1092,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1092,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1092,6,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1092,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1092,8,Migraine without aura,Migraine headaches,Headaches,Nerv,N
1092,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1092,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1092,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1092,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1092,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1093,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1094,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1095,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1095,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1095,3,Headache,Headaches NEC,Headaches,Nerv,N
1095,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1095,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1095,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1095,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1096,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1097,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1098,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1099,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1100,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1100,2,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1100,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1100,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1100,5,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1100,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1100,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1100,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1101,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1102,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1103,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1104,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1105,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1105,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1106,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1107,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1108,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1108,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1108,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1109,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1110,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1111,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1114,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1116,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1116,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1117,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1117,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1117,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1118,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1119,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1120,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1122,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
1122,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1122,3,Mandibular mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1122,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1122,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1122,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1122,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1122,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1122,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1122,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1122,12,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1122,13,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1122,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,15,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1122,16,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1122,17,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1123,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1124,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1125,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1125,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1125,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1126,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1126,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1127,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1128,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1128,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1129,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1129,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1130,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1131,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1131,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1131,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1131,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1131,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1133,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1134,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1135,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1136,1,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1138,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1139,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1139,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1140,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1140,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1142,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1142,2,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1144,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1144,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1145,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1145,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1147,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1148,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1148,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1149,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1149,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1150,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1151,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1151,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1152,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1152,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1152,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1152,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1152,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1152,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1152,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1153,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1154,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1155,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1156,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1157,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1157,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1157,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1157,4,Headache,Headaches NEC,Headaches,Nerv,N
1157,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1157,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1157,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1158,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1159,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1160,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1161,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1162,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1163,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1165,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
1166,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1169,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1169,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1170,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1170,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1170,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1170,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1170,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1170,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1170,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1172,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1173,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1174,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1174,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1175,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1175,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1176,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1177,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1178,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
1179,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1179,2,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
1179,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1180,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1181,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1182,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1182,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1183,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1184,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1184,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1184,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1184,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1185,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1185,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1185,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1186,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1187,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1187,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1189,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
1189,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1189,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1190,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1191,1,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1192,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1192,2,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1193,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1194,1,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1195,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1196,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1197,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1198,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1199,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1199,2,Pseudopolyp,Inflammations,General system disorders NEC,Genrl,N
1199,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1200,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1201,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1201,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1201,3,Lateral medullary syndrome,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1202,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1202,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1202,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1202,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1202,5,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1203,1,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1203,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1203,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1203,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1203,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1203,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1204,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1206,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1207,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1207,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1208,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1208,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1209,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1209,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1210,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1211,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1212,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1212,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1214,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1216,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1216,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1216,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1216,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1216,5,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1216,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1216,7,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1216,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1216,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1216,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1216,11,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1216,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1216,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1217,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1217,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1217,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1217,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1217,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1217,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1217,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1218,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1218,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1218,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1218,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1219,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1220,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1220,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1220,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1221,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1221,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1222,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1225,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1225,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1225,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1225,4,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1225,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1225,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1225,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1225,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1225,9,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1227,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1228,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1229,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1229,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1229,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1229,4,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1229,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1229,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1229,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1229,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1229,9,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1229,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1229,11,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
1229,12,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1229,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1229,14,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1229,15,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1229,16,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1230,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1230,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1230,3,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1230,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1230,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1230,6,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1230,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1230,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1230,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1231,1,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
1231,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1231,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1231,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1231,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1231,6,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,N
1232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1233,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1233,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1233,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1233,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1233,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1233,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1233,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1234,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1235,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1235,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1236,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1236,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1237,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1237,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1237,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1238,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1238,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1238,3,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
1238,4,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
1238,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1238,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1239,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1240,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1241,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1242,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1243,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1244,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1245,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1246,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1247,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1248,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1249,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1250,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1251,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1252,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1253,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1254,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1255,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1256,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1257,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1258,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1259,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1259,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1259,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1260,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1261,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1261,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1262,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1263,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1264,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1266,1,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
1267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1267,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1267,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1267,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1268,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1268,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1268,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1268,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1268,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1268,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1268,8,Chronic graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1268,9,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1268,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1268,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1268,12,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1269,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1269,2,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1269,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1269,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1269,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1269,6,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1269,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1269,8,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1269,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1269,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1269,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1269,12,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1269,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1269,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1269,15,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1269,16,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1271,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1272,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1275,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1275,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1276,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1277,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1277,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1277,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1278,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1278,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1278,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1279,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1281,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1282,1,Anti-insulin antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1282,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1282,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1282,4,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
1282,5,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1282,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1282,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1283,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1283,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,3,Headache,Headaches NEC,Headaches,Nerv,N
1283,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1283,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1283,6,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1284,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1284,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1284,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1284,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1284,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1285,1,Pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1285,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1286,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1287,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1287,2,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1287,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1287,4,Headache,Headaches NEC,Headaches,Nerv,N
1287,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1287,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,7,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
1287,8,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1287,9,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1287,10,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1287,11,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1288,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1288,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1289,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1289,2,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1289,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1289,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1290,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1290,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1290,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1290,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1290,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1290,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1290,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1290,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1290,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1290,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1291,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1291,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1291,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1291,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1292,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1293,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1293,2,Pelvic deformity,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1293,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1294,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1295,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1296,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1296,2,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1296,3,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1296,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1296,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1296,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1296,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1297,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1297,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1297,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1297,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1297,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1297,6,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1297,7,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1297,8,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1297,9,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1297,10,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1297,11,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1297,12,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1297,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1297,14,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
1298,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1298,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1298,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1298,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1298,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1299,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1300,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1301,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1302,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1303,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1303,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1303,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1304,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1305,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1306,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1306,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1307,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1307,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,3,Headache,Headaches NEC,Headaches,Nerv,N
1307,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1307,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1307,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1307,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1307,8,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1308,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1309,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1309,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
1309,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1309,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1310,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1310,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1310,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1311,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1311,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1311,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1311,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1311,5,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1312,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1312,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1312,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1312,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1312,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1313,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1313,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
1313,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1313,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1314,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1314,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1314,3,Headache,Headaches NEC,Headaches,Nerv,N
1314,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1314,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1315,1,Headache,Headaches NEC,Headaches,Nerv,N
1315,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1315,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1315,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1316,1,Jejunal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1316,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1316,3,Skin squamous cell carcinoma metastatic,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
1317,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1317,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1317,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1317,4,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1317,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1317,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1317,7,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1317,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1317,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1317,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1317,11,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1317,12,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1318,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1318,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1318,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1318,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1318,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1319,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1319,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1320,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1320,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1320,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1321,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1321,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1321,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1321,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1322,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1322,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1323,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1323,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1323,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
1323,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1323,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1323,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1323,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1323,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1323,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1323,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1323,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1323,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1323,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1323,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1323,15,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1324,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1324,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1325,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1325,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1325,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1325,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1325,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1325,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1325,7,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1325,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1325,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1326,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1326,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1326,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1326,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1326,5,Nocardia sepsis,Nocardia infections,Bacterial infectious disorders,Infec,N
1326,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1327,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1328,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1328,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1329,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1330,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1330,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1330,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1330,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1330,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1330,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,7,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1330,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1330,9,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1330,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1331,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1331,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1331,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1331,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1331,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1331,6,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1331,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1332,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1333,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1333,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1333,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
1333,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1333,5,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1333,6,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
1333,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1334,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1335,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1336,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1337,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1337,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1338,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1338,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1338,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1338,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1338,5,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1339,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1339,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1339,3,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
1339,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1340,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1340,2,Biopsy lung abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1340,3,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1340,4,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1340,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1340,6,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1340,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1340,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1340,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1340,10,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1340,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1341,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1341,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1342,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1342,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1343,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1343,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1343,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1343,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1343,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1343,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1344,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1344,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1344,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1344,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1345,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1346,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1346,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1347,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1347,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1347,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1347,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1348,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1348,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1348,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1348,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1348,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1349,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1349,2,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1349,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1350,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1350,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1350,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1351,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1351,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1351,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1352,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1352,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1353,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1353,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
1353,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1353,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1354,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1354,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1354,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1354,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1354,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1354,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1355,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1356,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1356,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1356,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1357,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1357,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1357,3,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1357,4,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1358,1,Chronic allograft nephropathy,Transplant rejections,Immune disorders NEC,Immun,N
1358,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1359,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1359,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1360,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1360,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1360,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1360,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1361,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1361,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1361,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1361,4,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
1361,5,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1361,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1361,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1362,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1362,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1363,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1363,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1364,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1364,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1365,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1365,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1366,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1366,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1367,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1367,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1367,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1367,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1367,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1368,1,Clonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1368,2,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1369,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1369,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1369,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1370,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1371,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1372,1,Mucous membrane pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1372,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1373,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1374,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1374,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1374,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1375,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1375,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1375,3,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1376,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1376,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1376,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1376,4,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1376,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1376,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1376,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1376,8,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1376,9,Headache,Headaches NEC,Headaches,Nerv,N
1376,10,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1376,11,Lupus myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1376,12,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1376,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1376,14,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1376,15,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1376,16,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1376,17,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1376,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1377,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1377,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1378,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1378,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1379,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1379,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1380,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1380,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1381,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1381,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1381,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1381,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1381,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1381,6,Lupus myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1381,7,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1381,8,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1381,9,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1381,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1381,11,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1382,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1382,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1382,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1382,4,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
1382,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1383,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1383,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1383,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1383,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1384,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1384,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1384,3,Haemophilia,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
1384,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1385,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1386,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1387,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1388,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1388,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1388,3,Headache,Headaches NEC,Headaches,Nerv,N
1388,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1388,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1389,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1389,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1389,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1389,4,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1389,5,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1389,6,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1389,7,Headache,Headaches NEC,Headaches,Nerv,N
1389,8,Optic discs blurred,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1389,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1389,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1389,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1390,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1391,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1392,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1392,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1392,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1392,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1392,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1392,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1393,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1393,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1393,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1393,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1393,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1393,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1393,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1393,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1394,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1395,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1395,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1395,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1395,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1395,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1395,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1395,7,Headache,Headaches NEC,Headaches,Nerv,N
1395,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,9,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1395,10,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1395,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1395,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1395,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1396,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1396,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1397,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1397,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1397,3,Headache,Headaches NEC,Headaches,Nerv,N
1397,4,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1397,5,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1397,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1398,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1398,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1399,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1399,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1399,3,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1399,4,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
1399,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1399,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1400,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1400,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1400,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1400,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1400,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1400,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1400,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1400,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1401,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1401,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1401,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1401,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1402,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1402,2,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1403,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1404,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1405,1,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1405,2,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1406,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1406,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1406,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1407,1,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
1407,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1407,3,Iris coloboma,Iris and choroid disorders congenital,Eye disorders congenital,Cong,N
1407,4,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
1408,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1408,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1409,1,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1410,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1410,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1410,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1410,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1410,5,Faecal vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1410,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1410,7,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1410,8,Gastrointestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1410,9,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1410,10,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1410,11,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1410,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1411,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1412,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1412,2,Intestinal villi atrophy,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1413,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1413,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1414,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1414,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1415,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1416,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1417,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1417,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1417,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1417,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1418,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1418,2,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1418,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1418,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1419,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1419,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1419,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1419,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1419,5,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1419,6,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1419,7,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1419,8,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1419,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1419,10,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1419,11,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1419,12,Mucosal hypertrophy,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1419,13,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1419,14,Pharyngeal polyp,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1419,15,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1419,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1420,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1420,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1420,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1420,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1420,5,Scopulariopsis infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1420,6,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
1420,7,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1421,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1421,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1421,3,Coarctation of the aorta,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1421,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1421,5,Congenital diaphragmatic hernia,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
1421,6,Congenital nail disorder,Hair and nail disorders congenital,Skin and subcutaneous tissue disorders congenital,Cong,N
1421,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1421,8,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1421,9,Fryns syndrome,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1421,10,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1421,11,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1421,12,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
1421,13,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1421,14,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
1421,15,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
1422,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1422,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1423,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1423,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1423,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1423,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1424,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1425,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1425,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1425,3,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1425,4,Headache,Headaches NEC,Headaches,Nerv,N
1425,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1425,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1426,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1426,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1426,3,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1426,4,Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1426,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1426,6,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1426,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1426,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1426,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1426,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1426,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1427,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1427,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1427,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1428,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1429,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1429,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1430,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1431,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1431,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1431,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1431,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1431,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1431,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1431,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1431,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1431,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1431,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1431,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1431,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1431,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
1432,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1433,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1433,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1433,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1434,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1434,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1434,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1435,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1435,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1435,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1435,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1435,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1436,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1436,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1436,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1437,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1437,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1437,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1437,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1437,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1437,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1437,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1437,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1437,9,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1437,10,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1437,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1438,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1439,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1439,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1439,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1439,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1439,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1439,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1440,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1440,2,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1440,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1440,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1440,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1442,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1442,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1442,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1443,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1443,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1443,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1443,4,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1443,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1443,6,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1444,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1444,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1444,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1444,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1445,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1445,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1445,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1446,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1446,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1446,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1447,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1448,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1448,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1448,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1449,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1449,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1449,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1449,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1450,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1451,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1452,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1453,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1453,2,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1454,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
1454,2,Cutaneous lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1455,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1455,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1456,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1457,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1457,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1457,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1457,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1457,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1457,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1457,7,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1457,8,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1457,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1457,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1457,11,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1458,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1458,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1458,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1458,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1458,5,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1458,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1458,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1458,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1459,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1459,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1460,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1460,2,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1461,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1462,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1463,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1463,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1463,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1465,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1465,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1465,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1465,4,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1465,5,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1465,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1465,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1465,8,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1466,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1467,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1467,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1467,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1467,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1468,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1468,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1468,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1468,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1469,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1469,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1469,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1469,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1470,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1471,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1472,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1473,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1474,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1475,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1475,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1475,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1475,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1475,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1475,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1475,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1475,8,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1476,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1476,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1476,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1476,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1477,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1478,1,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
1478,2,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1479,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1480,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1481,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1482,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1482,2,Menopause,Age related issues,Age related factors,SocCi,N
1482,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1483,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1483,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1483,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1483,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1483,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1483,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1484,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1485,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1485,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1485,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1485,4,Babesiosis,Babesia infections,Protozoal infectious disorders,Infec,N
1485,5,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1485,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1485,7,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1485,8,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1485,9,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1485,10,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1485,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1485,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1485,13,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1485,14,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1485,15,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1485,16,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1485,17,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1485,18,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1485,19,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1485,20,Myalgia,Muscle pains,Muscle disorders,Musc,N
1485,21,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1485,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1485,23,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
1485,24,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1485,25,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1485,26,Skin turgor decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1486,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1486,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1487,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1487,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1487,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1487,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1488,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1488,2,Paternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1489,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1489,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1489,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1489,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1489,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1490,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1490,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1491,1,Acne,Acnes,Skin appendage conditions,Skin,N
1492,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1492,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1492,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1492,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1492,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1493,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1493,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1493,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1494,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1494,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1494,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1494,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1494,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1494,6,Headache,Headaches NEC,Headaches,Nerv,N
1494,7,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1494,8,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1494,9,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1494,10,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1494,11,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1494,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1495,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1495,2,Genitourinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1495,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1497,1,Blood alkaline phosphatase decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1497,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1497,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1498,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1499,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1499,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1500,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1500,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1500,3,Extremity contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1500,4,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1500,5,Headache,Headaches NEC,Headaches,Nerv,N
1501,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1502,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1502,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1503,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1504,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1504,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1504,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1504,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1504,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1504,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1505,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1505,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1506,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1506,2,Chloroma,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1507,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1508,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1508,2,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1508,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1508,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1508,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1509,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1509,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1510,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1510,2,Aortic occlusion,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1510,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1510,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1510,5,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1511,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1511,2,Chronic graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1511,3,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1511,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1511,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1512,1,Granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1512,2,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
1512,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1512,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1512,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1512,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1512,7,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1513,1,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1513,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1514,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1514,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1515,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1516,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1517,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1517,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1518,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1518,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1518,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1519,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1519,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1520,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1521,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1521,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1521,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1521,4,Engraftment syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1521,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1521,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1521,7,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1521,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1522,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1522,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1522,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1522,5,Myopathy,Myopathies,Muscle disorders,Musc,N
1522,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1522,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1523,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1523,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1523,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1523,4,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1523,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1524,1,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1524,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1524,3,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1524,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1524,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1525,1,Chloroma,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1526,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1526,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1526,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1526,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1526,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1526,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1526,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1527,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1527,2,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1528,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1530,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1531,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1532,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1533,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1534,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1534,2,Myocarditis toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1534,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1535,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1535,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1535,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1535,4,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1535,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1535,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1535,7,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1535,8,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,Y
1535,9,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1535,10,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1535,11,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1535,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,13,Neurologic neglect syndrome,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1535,14,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1535,15,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1536,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1537,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1537,2,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1537,3,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1537,4,External auditory canal atresia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
1537,5,External ear disorder,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
1537,6,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1537,7,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1537,8,Iris coloboma,Iris and choroid disorders congenital,Eye disorders congenital,Cong,N
1537,9,Kidney duplex,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1537,10,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1537,11,Retinal coloboma,Retinal disorders congenital,Eye disorders congenital,Cong,N
1538,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1538,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1538,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1539,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1539,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1539,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1539,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1540,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1540,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1541,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1542,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1542,2,Cutaneous malacoplakia,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1542,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1542,4,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1543,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1543,2,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1543,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1543,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1543,5,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1543,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1544,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1544,2,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1545,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1545,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1546,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1547,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1547,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1547,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1548,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1548,2,Oedematous kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1549,1,Infective exacerbation of bronchiectasis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1549,2,Oxygen consumption decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1549,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1550,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1551,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1551,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1552,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1552,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1552,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1553,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1553,2,Genital neoplasm malignant female,Female reproductive neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
1553,3,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1553,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1553,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1554,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1554,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1554,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1554,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1554,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1554,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1554,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1555,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1556,1,Central nervous system lupus,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1556,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1556,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1556,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1556,5,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1556,6,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
1557,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1558,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1559,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1559,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1559,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1560,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1560,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1561,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1561,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1562,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
1563,1,Encephalitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1564,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1565,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1565,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1565,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1566,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1566,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1567,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1568,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1569,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1569,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1569,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1571,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1571,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1572,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1572,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1573,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1573,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1574,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
1575,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1575,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1576,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1577,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1578,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1579,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1579,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1580,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1581,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1582,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1582,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1583,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1584,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1584,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1584,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1584,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1584,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1584,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1585,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1586,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1587,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1588,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1588,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1589,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1589,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1590,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1591,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1591,2,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1591,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1591,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1592,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1592,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1592,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1593,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1593,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1594,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1595,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1595,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1596,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1596,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1596,3,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1597,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1597,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1599,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1599,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1600,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1601,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1602,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1602,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1602,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1602,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1602,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1602,6,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1603,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1603,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1604,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1604,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1604,3,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1604,4,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1604,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1604,6,Pleural adhesion,Pleural conditions NEC,Pleural disorders,Resp,N
1604,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1604,8,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1604,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1604,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1605,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1605,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1605,3,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1605,4,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
1605,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1605,6,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1605,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1605,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1605,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1605,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1605,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1605,12,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1606,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1607,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1607,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1608,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1608,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1609,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1610,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1610,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1610,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1611,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1611,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1611,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1611,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1611,5,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1611,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1612,1,Coronavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1612,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1612,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1613,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1614,1,Bacterial translocation,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1615,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1615,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1615,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1615,4,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1615,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1615,6,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
1615,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1615,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1616,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1617,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1617,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1617,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1617,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1618,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1618,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1618,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1618,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1619,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1620,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1620,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1620,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1620,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1620,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1620,6,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
1620,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1621,1,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1621,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1621,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1621,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1621,5,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
1621,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1622,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1622,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1622,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1622,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1623,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1623,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1623,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1624,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1624,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1624,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1625,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1625,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1625,3,Micrococcal sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1625,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1626,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1627,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1627,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1627,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1627,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1627,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1627,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1628,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1628,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1628,3,Hepatitis infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1629,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1629,2,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1629,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1629,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,5,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1629,6,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1629,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1629,8,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1629,9,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1629,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1629,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1629,12,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1629,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1629,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1629,15,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,16,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1630,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1630,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1630,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1630,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1630,5,Microvillous inclusion disease,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1630,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1631,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1632,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1632,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1632,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1632,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1632,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1632,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1633,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1633,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1633,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1633,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1634,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1635,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1635,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1636,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1636,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1637,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1637,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1637,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1638,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1638,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1638,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1638,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1639,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1639,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1639,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1639,4,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1639,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1639,6,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1639,7,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
1639,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1639,9,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1639,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1640,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1640,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1640,3,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
1640,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1640,5,Ejection fraction,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1640,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1640,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1640,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1640,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1640,10,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1640,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1640,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1640,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1641,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1642,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1642,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1642,3,Disability,Disability issues,Lifestyle issues,SocCi,N
1642,4,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1643,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1644,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1644,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1645,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1646,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1646,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1647,1,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1648,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
1648,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1648,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1648,4,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
1649,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1649,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1649,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1649,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1650,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1651,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1651,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1651,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1651,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1651,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1652,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1652,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1652,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1652,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1652,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1652,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1652,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1653,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1654,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1655,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1655,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1655,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1656,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1657,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1658,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1658,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1659,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1659,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1659,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1659,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1659,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1659,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1659,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1659,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1659,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1660,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1660,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1660,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1660,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1661,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1662,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1663,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1663,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1664,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1665,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1665,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1665,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1665,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1665,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1666,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1666,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1667,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1667,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1667,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1667,4,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1667,5,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1668,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1669,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1669,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1670,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1671,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1672,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1672,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1673,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1674,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1675,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1676,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1677,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1677,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1678,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1678,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1678,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1679,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1679,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1680,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1681,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1682,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1682,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1682,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1682,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1683,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1684,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1685,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1685,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1685,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1686,1,Adenovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1686,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1686,3,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1686,4,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1686,5,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1686,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1686,7,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1686,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1686,9,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1687,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1687,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1687,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1687,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1688,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1689,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1689,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1689,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1690,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1691,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1692,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1693,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1694,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1694,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1695,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1696,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1696,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1697,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1698,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1698,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1698,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1699,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1700,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1701,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1701,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1702,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1703,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1703,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1703,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1703,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1704,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1704,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1704,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1705,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1705,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1706,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1706,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1707,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1707,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1708,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1708,2,Headache,Headaches NEC,Headaches,Nerv,N
1708,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1709,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1709,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1709,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1709,4,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
1710,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1711,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1712,1,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1713,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1714,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1715,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1715,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1715,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1715,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1715,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1715,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1715,7,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1715,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1715,9,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1715,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1716,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1717,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1718,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1718,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1718,3,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1718,4,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1718,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1718,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1718,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1718,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1718,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1718,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1719,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1720,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1720,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1721,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1721,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1722,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1722,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1722,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
1722,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1723,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1723,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1724,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1724,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1725,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1726,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1726,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1726,3,Cytomegalovirus mucocutaneous ulcer,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1726,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1726,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1726,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1727,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1727,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1727,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1727,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1727,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1727,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1727,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1728,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1729,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1729,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1729,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1730,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1730,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1730,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1730,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1730,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1731,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1731,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1731,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1731,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1731,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1732,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1733,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1733,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1733,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1733,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1733,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1733,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1733,7,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1733,8,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1733,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1733,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1733,11,Hyperferritinaemia,Iron excess,Iron and trace metal metabolism disorders,Metab,N
1733,12,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
1733,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1733,14,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1733,15,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1733,16,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1733,17,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1733,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1733,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1733,20,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1733,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1733,22,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1734,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1734,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1735,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1735,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1735,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1735,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1735,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1735,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1735,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
1735,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1735,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1735,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1735,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1735,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1735,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1735,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1735,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1735,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1735,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1735,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1735,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1735,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1735,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1736,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1736,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1736,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1736,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1736,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1736,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1736,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1736,8,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1736,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1736,10,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1736,11,Trichosporon infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1737,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1737,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1737,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
1737,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1737,5,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1737,6,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1738,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1738,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1738,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1739,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1739,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1739,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1740,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1741,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1742,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1743,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1743,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1744,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1744,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1744,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1745,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1746,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1747,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1748,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1750,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1750,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1750,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1750,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1750,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1750,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1750,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1750,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1750,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1751,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1751,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1752,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1753,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1753,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1754,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1754,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1755,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1756,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1756,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1757,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1757,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1757,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1757,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1757,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1757,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1757,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1758,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1758,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1759,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1759,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1760,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1761,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1761,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1762,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1763,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1764,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1764,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1764,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1765,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1766,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1767,1,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
1768,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1768,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1768,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1769,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1769,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1769,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1769,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1769,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1770,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1771,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1771,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1771,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1771,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1771,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1771,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1771,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
1771,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1771,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1771,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1771,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1771,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1771,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1771,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1771,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1771,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1771,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1771,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1771,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1771,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1771,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1772,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1773,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1774,1,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1775,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1776,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1776,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1777,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1777,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1777,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1778,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1778,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1778,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1778,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1779,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1779,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1779,3,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
1780,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1780,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1780,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1780,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1780,5,Obstructive nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1780,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1780,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1781,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1781,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1781,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1781,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1782,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1782,2,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
1782,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1783,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1783,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1783,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1783,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1783,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1784,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1784,2,Entropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
1784,3,Symblepharon,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1785,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1785,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1785,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1785,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1786,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1787,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1788,1,Headache,Headaches NEC,Headaches,Nerv,N
1788,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1788,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1789,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1790,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1790,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1791,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1791,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1791,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1791,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1792,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1793,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,3,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1793,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1793,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1794,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1795,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1796,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1796,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1797,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1798,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1799,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1799,2,Headache,Headaches NEC,Headaches,Nerv,N
1799,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1799,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1800,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1800,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1800,3,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1800,4,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
1800,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1801,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1801,2,Headache,Headaches NEC,Headaches,Nerv,N
1801,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1801,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
1801,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1801,6,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1801,7,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1801,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1801,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1802,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1802,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1802,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,4,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1802,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1802,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1802,7,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1802,8,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1802,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1802,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1802,11,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1802,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1802,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1802,14,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1803,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1804,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1804,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1804,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1804,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1805,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1806,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1806,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1807,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1808,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1808,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1809,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1809,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1809,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1809,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1810,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1810,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1810,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1811,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1811,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1811,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1811,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1812,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1812,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1812,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1812,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1813,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1813,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1813,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1813,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1814,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1814,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1814,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1814,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1814,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1815,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1815,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1815,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1815,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1816,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1816,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1816,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1816,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1817,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1818,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1818,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1818,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1818,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1818,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1818,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1818,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1819,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1819,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1819,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1819,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1820,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1821,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1822,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1822,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1823,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1824,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1825,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1826,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1827,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1827,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1827,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1827,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1827,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1827,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1827,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1828,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1829,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1830,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1831,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1831,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1831,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1831,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1831,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1832,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1832,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1832,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1833,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1833,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1833,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1834,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1835,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1836,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1836,2,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1836,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1836,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1837,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1838,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1838,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1839,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1839,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1839,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1839,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1840,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1840,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1840,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1840,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1840,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1840,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1840,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1840,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1840,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1841,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1842,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1842,2,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
1842,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1842,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1842,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1843,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1844,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1845,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1845,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1845,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1845,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1845,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1845,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1845,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1845,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1845,9,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1846,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1847,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1848,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1849,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1849,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1849,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1849,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1849,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1849,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1849,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1849,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1849,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1849,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1850,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1850,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1850,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1850,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1851,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
1851,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1851,3,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1852,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1852,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1853,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1853,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1854,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1855,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1856,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1856,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1857,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1858,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1859,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1859,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1860,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1861,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1861,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1861,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1861,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1861,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1861,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1861,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1862,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1862,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1863,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1864,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1865,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1866,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1866,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1866,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1867,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1867,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1867,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1868,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1868,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1869,1,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1869,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1870,1,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1871,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1872,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1873,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1874,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1874,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1874,3,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1874,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1875,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1875,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1876,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1876,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1877,1,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1877,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1878,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1879,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1879,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1880,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1881,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1882,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1883,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1883,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1883,3,Headache,Headaches NEC,Headaches,Nerv,N
1883,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1884,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1884,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1884,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1884,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1885,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1885,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1885,3,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1885,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1886,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1886,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1886,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1887,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1887,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1888,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1888,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1888,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1888,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1888,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1888,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1888,7,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1888,8,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1888,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1888,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1888,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1888,12,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
1888,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1889,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1890,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1891,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1892,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1892,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1892,3,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1893,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1894,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1894,2,Herpes simplex viraemia,Herpes viral infections,Viral infectious disorders,Infec,N
1894,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1895,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1895,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1895,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1895,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1895,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1895,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1896,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1896,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1897,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1898,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1898,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1899,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1900,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1901,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1902,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1903,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1903,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1904,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1904,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1905,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1905,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1906,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1906,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1907,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1907,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1907,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1907,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1908,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1909,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1909,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1909,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1910,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1910,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1910,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1911,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1911,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1911,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1912,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1912,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1912,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1913,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1913,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1913,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1914,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1914,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1914,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1915,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1915,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1915,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1916,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1916,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1916,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1917,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1917,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1917,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1918,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1918,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1919,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1919,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1920,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1920,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1920,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1920,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1921,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1921,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1922,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1922,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1923,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1923,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1924,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1924,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1924,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1925,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1926,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1927,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1928,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1928,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1929,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1930,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1930,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1931,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1931,2,Headache,Headaches NEC,Headaches,Nerv,N
1931,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1932,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1933,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1933,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1934,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1934,2,Headache,Headaches NEC,Headaches,Nerv,N
1934,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1934,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1935,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1936,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1937,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1938,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1938,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1940,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1941,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1942,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1943,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1943,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1944,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1944,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1945,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1946,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1946,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1947,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1948,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1949,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1950,1,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1950,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1950,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1951,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1952,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1953,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1954,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1955,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1956,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1956,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1956,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1957,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1957,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1958,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1958,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1958,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1959,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1959,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1960,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1960,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1960,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1962,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1962,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1962,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1963,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1963,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1964,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1965,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1966,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1966,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1966,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1967,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1968,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1968,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1968,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1968,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1968,5,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1968,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1969,1,Cat scratch disease,Bartonella infections,Bacterial infectious disorders,Infec,N
1969,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1970,1,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1970,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1971,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1972,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1972,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1972,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1972,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1973,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1973,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1973,3,Headache,Headaches NEC,Headaches,Nerv,N
1973,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1973,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1973,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1973,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1973,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1973,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1974,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1975,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1975,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1976,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1977,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1978,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1979,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1981,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1981,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1982,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1982,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1982,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1983,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1983,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1983,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1984,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1985,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1986,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1987,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1987,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1988,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1988,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1989,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1989,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1990,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1991,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1992,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1993,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1994,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1994,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1995,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1995,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1996,1,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1996,2,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1996,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1997,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1998,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1998,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1998,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
1999,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2000,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2001,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2001,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2001,3,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2002,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2003,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2004,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2004,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2005,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2005,2,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2005,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2005,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2005,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2005,6,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2005,7,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2005,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2006,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2007,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2008,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2009,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2010,1,Angiocentric lymphoma,Angiocentric lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
2010,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2011,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2012,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2012,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2013,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2014,1,Angiocentric lymphoma,Angiocentric lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
2015,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2015,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2015,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2015,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2015,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2015,6,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2015,7,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2015,8,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2015,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2017,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2017,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2018,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2019,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2020,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2021,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2021,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2022,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
2023,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2024,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
2024,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2025,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2025,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2025,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2025,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2025,5,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2025,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2025,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2026,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2027,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2028,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2029,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2030,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2031,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2032,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2032,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2033,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2034,1,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
2035,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2036,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2036,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2036,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2036,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2036,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2036,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2036,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2036,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2037,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2038,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2038,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2038,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2038,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2038,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2038,6,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
2038,7,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2038,8,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2038,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2038,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2038,11,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2038,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2039,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2040,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2040,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2040,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2041,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2041,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2041,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2041,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2041,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2041,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2041,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2041,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2042,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2043,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2043,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2044,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2045,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2046,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2046,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2047,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2047,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2048,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2048,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2049,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2050,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2050,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2050,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2050,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2051,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2051,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2051,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2051,4,Mucous membrane pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
2052,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2052,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2053,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2053,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2054,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2055,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2056,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2056,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2057,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2057,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2057,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2058,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2058,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2058,3,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2058,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2058,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2059,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2059,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2059,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
2059,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2060,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2060,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2061,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2061,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2061,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2062,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2062,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2063,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2063,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2063,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2064,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2065,1,Drug level fluctuating,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2065,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2066,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2067,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2067,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2067,3,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2067,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2068,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2068,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2068,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2068,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2069,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2070,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2071,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2071,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2072,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2073,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2074,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2075,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2076,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2076,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2077,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2078,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2078,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2078,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2079,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2080,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2080,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2080,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2081,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2082,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2083,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2083,2,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
2084,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2084,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2084,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2085,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2086,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2086,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2087,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2087,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2087,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2087,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2088,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2089,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2089,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2090,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2090,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2091,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2091,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2091,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2092,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2092,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2093,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2093,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2093,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2094,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
2095,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2096,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2096,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2097,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2097,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2098,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2098,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2098,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2099,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2099,2,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2099,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2099,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2099,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2099,6,Migraine,Migraine headaches,Headaches,Nerv,N
2099,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2099,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2100,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2101,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2101,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2101,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2102,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2103,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2103,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2104,1,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2105,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
2106,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2107,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2108,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2108,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2110,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2111,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2112,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2113,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2113,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2113,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2113,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2113,5,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2114,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2115,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2116,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2117,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2118,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2119,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2120,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2121,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2122,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2123,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2124,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2125,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2126,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2127,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
2128,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2128,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2129,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2129,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2129,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2130,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2130,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2130,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2130,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2130,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
2131,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2132,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2133,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2134,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2134,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2135,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2136,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2136,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2136,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2136,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2136,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2136,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2136,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2136,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
2136,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2136,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2136,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2136,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2137,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2138,1,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2138,2,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2139,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2140,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2140,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2140,3,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
2140,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2141,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2141,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2141,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2141,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2141,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2141,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2141,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2141,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
2141,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2141,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2141,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2141,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2142,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2143,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2143,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2143,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2144,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2144,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2144,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2144,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2144,5,Oxygen consumption increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2145,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2145,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2146,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2146,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2146,3,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2146,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2146,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2147,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2148,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2149,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2150,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2151,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2152,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2153,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2153,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2154,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2155,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2155,2,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2155,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2155,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2156,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2156,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2157,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2158,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2158,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2158,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2159,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2159,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2160,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2160,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2161,1,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2161,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2162,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2163,1,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
2163,2,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2164,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2164,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2165,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2166,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2166,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2167,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2167,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2167,3,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2167,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2167,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2169,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2170,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2171,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2171,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2172,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2173,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2174,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2175,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2176,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2176,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2177,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2178,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2179,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2179,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2180,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2180,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2182,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2183,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2184,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2185,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2185,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2185,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2186,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2186,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2186,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2187,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2188,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2188,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2189,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2189,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2190,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2191,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2192,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2193,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2195,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2195,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2196,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2196,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2197,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2198,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2199,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2201,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2202,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2202,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2203,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2204,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2204,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2205,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2206,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2206,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2207,1,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
2208,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2208,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2209,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2210,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2210,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2211,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2212,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2214,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2214,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2216,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2217,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2218,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2218,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2219,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2220,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2221,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2221,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2222,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2223,1,Herpes zoster reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2224,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
2225,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2226,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2226,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2227,1,Headache,Headaches NEC,Headaches,Nerv,N
2228,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2228,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2228,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2228,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2228,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2228,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2229,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2230,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2230,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2230,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2231,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2232,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2232,2,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2233,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2234,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2234,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2234,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2234,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2235,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2235,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2236,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2237,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2237,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2238,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2238,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2239,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2240,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2241,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2242,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2243,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2244,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2244,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2245,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2245,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2245,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2246,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
2247,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
2248,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2248,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2249,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2250,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2251,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2251,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2251,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2252,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2253,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2253,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2254,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2254,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2255,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2255,2,Mycobacterium haemophilum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2255,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2256,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2256,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2256,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2257,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2257,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2257,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2258,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2258,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2259,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2259,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2260,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2260,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2260,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2261,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2261,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2261,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2262,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2262,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2263,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2264,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2265,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2265,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2265,3,Blood antidiuretic hormone,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
2265,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2265,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2265,6,Headache,Headaches NEC,Headaches,Nerv,N
2265,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2265,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2265,9,Hypertensive emergency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
2265,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2265,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2266,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
2266,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2267,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2267,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2267,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
2267,4,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2267,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2268,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2268,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2269,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2270,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2271,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2271,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2272,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2272,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2272,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2272,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2272,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2273,1,Coronary artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
2273,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2274,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2275,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2275,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2276,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2276,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2276,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2276,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2276,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2277,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2278,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2278,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2278,3,Donor specific antibody present,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
2278,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2278,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2279,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2280,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2280,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2281,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2282,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2283,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2283,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2284,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2284,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2285,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2286,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2286,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2286,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2286,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2287,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2288,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2289,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2289,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2290,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2290,2,Feeding tube user,Dietary and nutritional issues,Lifestyle issues,SocCi,N
2291,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2291,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2292,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2293,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2294,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2295,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2296,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2297,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2298,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2299,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2299,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2300,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2300,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2300,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2302,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2303,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2303,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2303,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2303,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2303,5,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2304,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2305,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2306,1,Headache,Headaches NEC,Headaches,Nerv,N
2307,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2309,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2311,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2312,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2312,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2312,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
2313,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2313,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2314,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2314,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
2315,1,White blood cell count,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2316,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2317,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2318,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2319,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2319,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2320,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2320,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2320,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2321,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,Y
2322,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2322,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2323,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2323,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2324,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2324,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2324,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2324,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2324,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2324,6,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2324,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2324,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2325,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2325,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2327,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2328,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
2328,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2328,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2328,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2329,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2330,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2330,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2330,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2331,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2332,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2333,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2333,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2333,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2333,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2334,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2335,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2335,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2335,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2336,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2336,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2337,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2337,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2338,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2338,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2338,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2339,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2340,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2340,2,Thyrotoxic periodic paralysis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2341,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2342,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2342,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2342,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2343,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2343,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2343,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2344,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2345,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2345,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2346,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2346,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2347,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2347,2,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
2347,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2348,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2348,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2348,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2348,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2348,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2348,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2348,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2349,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2349,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2350,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2350,2,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2350,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2351,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2351,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2351,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2352,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2352,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2352,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2353,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2353,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2353,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2353,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2353,5,Renal graft infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2353,6,Vitamin D increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2354,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2354,2,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
2355,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2355,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2355,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2356,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2357,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2357,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2357,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2358,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2359,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2360,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2360,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2360,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2360,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2360,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2360,6,Tension headache,Headaches NEC,Headaches,Nerv,N
2361,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2361,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2362,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2363,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2363,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2364,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2365,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2365,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2366,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2367,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2368,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2369,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2370,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2370,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2370,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2371,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2372,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2373,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2374,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2375,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2376,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2376,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2376,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2376,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2377,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2377,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2377,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2377,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2378,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2378,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2378,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2378,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2379,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2379,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2379,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2380,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2380,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2381,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2382,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2382,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
